Development and Application of Cancer Stem Cell-Targeted Vaccine in Cancer Immunotherapy
MEFA (multiepitope fusion antigen)-Novel Technology for Structural Vaccinology, Proof from Computational and Empirical Immunogenicity Characterization of an Enterotoxigenic Escherichia coli (ETEC) Adhesin MEFA
Journal of Vaccines & Vaccination received 2051 citations as per Google Scholar report
VRDD Naval Medical Research Center USA
K. Raviprakash is a Senior Scientist at Naval Medical Research Center, USA.